Aura Biosciences, Inc.
Aura Biosciences, Inc.（AURA）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
aura · 股价预测 · 8 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 8 位华尔街分析师
Buy
8 位分析师
共识
评级分布
12 个月目标价
High
$17.00
Consensus
$17.00
+161.4% upside
Low
$17.00
Median: $17 · Last Close: $6.50
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $6.18 | ↓ 5.00% |
1-day model range: $6.13–$6.23. Peak: $6.23 (-5.00%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $4 | -36.5% |
| 2028 | $3 | -49.3% |
| 2029 | $3 | -54.9% |
| 2030 | $3 | -57.6% |
| 2031 | — | -59.0% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · AURA · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-29 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-30 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-08-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-05-23 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2025-03-26 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2025-03-26 | Citizens Capital Markets | Maintains | Market Outperform→Market Outperform |
| 2025-03-25 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-24 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-12-05 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2024-11-14 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Aura Biosciences, Inc. (AURA) stock. Of the recent 25 rating actions, 0 were upgrades and 0 were downgrades. 8 analysts currently cover AURA.
分析师推荐趋势
AURA analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$19M
↓ 32.0% YoY
Revenue Next Year
$8M
↓ 59.8% YoY
EPS This Year
$-1.59
EPS Next Year
$-1.67
↑ 4.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast AURA EPS of $-1.59 for the current fiscal year, based on estimates from 3 analysts. The AURA revenue forecast is $19M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
AURA 股价预测由两类独立数据源支撑：来自 8 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。AURA 的共识目标价为 $17.00（+161.4% 上行空间），分析师共识为 Buy。
AURA 的短期预测（明日）为 $6.18（-5.00%）。 AURA 对 2027 年的股价预测均值为 $4。 AURA 对 2030 年的预测区间为 $3–$3。
Aura Biosciences, Inc. 在 NASDAQ 上市，代码 AURA。AURA 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
AURA 预测 · 8 个问题根据 8 位华尔街分析师，AURA 的 12 个月平均目标价为 $17.00，最高 $17.00、最低 $17.00。若有图表，中位目标价可在上方查看。相对当前价 $6.50，隐含约 +161.4% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.